V

Virax Biolabs Group Ltd
NASDAQ:VRAX

Watchlist Manager
Virax Biolabs Group Ltd
NASDAQ:VRAX
Watchlist
Price: 0.359 USD -2.97% Market Closed
Market Cap: 1.6m USD

Wall Street
Price Targets

VRAX Price Targets Summary
Virax Biolabs Group Ltd

There are no price targets for VRAX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Virax Biolabs Group Ltd Competitors:
Price Targets
COR
Cencora Inc
15% Upside
NEU
Neuca SA
1% Downside
GALE
Galenica AG
9% Downside
CAH
Cardinal Health Inc
5% Upside
PHARMA
Pharmaniaga Bhd
24% Downside
ILM1
Medios AG
67% Upside
SIG
Sigma Healthcare Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
Virax Biolabs Group Ltd

For the last 4 years the compound annual growth rate for Virax Biolabs Group Ltd's revenue is -52%. The projected CAGR for the next 2 years is 2 445%.

-52%
Past Growth
2 445%
Estimated Growth
Estimates Accuracy
-89%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Virax Biolabs Group Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Virax Biolabs Group Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VRAX's stock price target?
Not Available

VRAX doesn't have any price targets made by Wall Street professionals.

What is Virax Biolabs Group Ltd's Revenue forecast?
Projected CAGR
2 445%

For the last 4 years the compound annual growth rate for Virax Biolabs Group Ltd's revenue is -52%. The projected CAGR for the next 2 years is 2 445%.

Back to Top